Companies: 10,795·Total market cap: $144.5T
Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc.

ZBHNYSEHealthcare● Active
$87.44
+$0.11(+0.13%)
Market Cap$16.9B
P/E Ratio
52W High$108.29
52W Low$79.12
Overview

Zimmer Biomet Holdings, Inc. (ZBH) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ZBH · as of Jun 8, 2026

Key Statistics

EPS (TTM)$3.87zbh eps ttm · zbh earnings per shareEarnings history
PE Ratio (TTM)22.6×zbh pe ratio ttm · zbh price to earningsPE Ratio deep dive
Revenue (TTM)$8.4Bzbh revenue ttm · zbh annual revenueFull revenue history
Dividend Yield1.10%does zbh pay dividends · zbh dividend yieldDividend history
Shares Outstanding198.0Mzbh shares outstanding · zbh floatShares outstanding history
Next EarningsAug 6, 2026Est.zbh earnings date · zbh next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$8.23B▲ +7.20% YoY
202320242025
zimmer biomet holdings, inc. revenue · zbh revenue 2025
FY 2025Net Income$705.2M▼ 21.97% YoY
202320242025
zimmer biomet holdings, inc. net income · zbh profit 2025
FY 2025EPS$3.56▼ 20.00% YoY
202320242025
zbh eps · zimmer biomet holdings, inc. earnings per share 2025
TTM:Revenue: $8.41BNet Income: $761.3MEPS: $3.87View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold42 analystsis zbh a buy · zbh analyst rating
Strong Buy
0
Buy
18
Hold
21
Sell
3
Strong Sell
0
12-Month Price Target
$83.00Low
$87.44Current
$96.33Avg Target10.17% upside
$120.00High
zbh price target · zbh 12 month forecast

Total: 42 · Buy rate: 42.9%

The ZBH analyst consensus is Hold, based on ratings from 42 Wall Street analysts over the past 3 months. The average 12-month price target is $96.33, representing +10.17% upside from the current price of $87.44.

Stock Performance

Full History
1D+0.82%
1W+5.27%
1M+6.95%
3M-6.44%
YTD-2.08%
1Y-5.15%
5Y-42.39%

About Zimmer Biomet Holdings, Inc.

CEOIvan Tornos
IPO DateJul 25, 2001
Employees17,000
CountryUS

Zimmer Biomet Holdings, Inc. together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company de…

what is zimmer biomet holdings, inc. · zbh stock overview · zimmer biomet holdings, inc. company profile · who is zimmer biomet holdings, inc. ceo · zbh NYSE · zimmer biomet holdings, inc. headquarters · zimmer biomet holdings, inc. business segments

About Stock Overview & Key Data

Zimmer Biomet Holdings, Inc. (ZBH) is a Healthcare company in the Medical - Devices industry, listed on NYSE since Jul 25, 2001. As of the latest trading session, ZBH stock price is $87.44, with a market capitalization of $16.9B. The stock has returned -5.15% over the past 12 months and -2.08% year-to-date.

According to 42 Wall Street analysts, the consensus rating for Zimmer Biomet Holdings, Inc. stock is Hold, with an average 12-month price target of $96.33. In fiscal year 2025, Zimmer Biomet Holdings, Inc. reported revenue of $8.2B and net income of $705.2M. For detailed data — including Zimmer Biomet Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Zimmer Biomet Holdings, Inc. (ZBH) stock price is $87.44. The stock is traded on NYSE under the ticker symbol ZBH. The 52-week range is $79.12 – $108.29.

ZBH stock priceZBH quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice